Invivyd, Inc.
Invivyd, Inc.（IVVD）股东结构
基于 13F 申报与流通股数据，展示机构、内部人与公众持股结构；下方为前十大机构、机构动向与内部人交易。
SEC 13F · FMP · IVVD · 截至 2025年9月30日
股东结构概览
82
机构持有人数
▲ 15 vs Q2
$163.79M
机构持仓总市值
▲ $120.57M vs Q2
132.73M
总流通股
freeFloat 66.17%
148.79M
13F 申报持股数
▲ 88.34M vs Q2
机构持仓% = 13F 持股数 ÷ 总流通股。内部人% = 100 − 自由流通率。散户% = 自由流通率 − 机构%。数据来源：FMP /symbol-positions-summary + /shares-float + SEC EDGAR。
前10大机构持仓
IVVD 最大股东 · 机构持仓
Q3 2025 · SEC 13F
显示前 10 家
| 机构 | 持股数 | 占比 | 权重 | 市值 | 申报日 | 变动 |
|---|---|---|---|---|---|---|
JANUS HENDERSON GROUP PLC biological products, (no diagnostic substances) | 25.38M | 14.92% | 14.92% | $28.05B | Nov 14, 2025 | NEW |
POINT72 ASSET MANAGEMENT, L.P. biological products, (no diagnostic substances) | 20.30M | 11.93% | 11.93% | $22.33B | Nov 14, 2025 | NEW |
MAVERICK CAPITAL LTD biological products, (no diagnostic substances) | 18.97M | 11.15% | 11.15% | $20.87B | Nov 14, 2025 | ▲ 8.74M |
RA CAPITAL MANAGEMENT, L.P. biological products, (no diagnostic substances) | 17.12M | 10.06% | 10.06% | $18.83B | Nov 14, 2025 | NEW |
MITHRIL II GP LP biological products, (no diagnostic substances) | 11.24M | 6.61% | 6.61% | $12.37B | Nov 12, 2025 | — held |
DRIEHAUS CAPITAL MANAGEMENT LLC biological products, (no diagnostic substances) | 10.11M | 5.94% | 5.94% | $11.12B | Nov 14, 2025 | NEW |
M28 CAPITAL MANAGEMENT LP biological products, (no diagnostic substances) | 9.25M | 5.43% | 5.43% | $10.17B | Nov 13, 2025 | — held |
ADAR1 CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 7.37M | 4.33% | 4.33% | $8.11B | Nov 14, 2025 | NEW |
683 CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 6.30M | 3.70% | 3.70% | $6.93B | Nov 14, 2025 | ▲ 3.23M |
VANGUARD GROUP INC biological products, (no diagnostic substances) | 5.76M | 3.39% | 3.39% | $6.34B | Nov 7, 2025 | ▲ 1.83M |
数据来源：SEC 13F 申报文件。变动标识：isNew / isSoldOut / changeInSharesNumber。
机构仓位变动
Q3 2025 对比上季度
Q3 2025
20
增持
+16.60M 股14
新建仓
首次建仓8
减持
−3.00M 股0
清仓
完全退出净股数变化（前50家）
+13.60M
+16.60M / −3.00M
净新增持仓人
+26
新建 14 个 / 退出 0 个
基于前50家最大机构持仓统计，全市场实际数量可能不同。
内幕交易买卖情绪
IVVD 内幕交易记录
数据来源：SEC Form 4
近期内部人员以卖出为主。 卖出可能源于预定的 10b5-1 计划，不代表负面展望。
6
买入笔数
0
卖出笔数
0.00
买卖比
$0M
卖出总金额
最近内幕交易记录
最近10条 · 仅普通股
| 姓名 · 职位 | 日期 | 类型 | 股数 | 价格 | 金额 | 交易后持股 | 申报 |
|---|---|---|---|---|---|---|---|
Royan Ajay director | May 19, 2026 | Award | 50,000 | $1.04 | $52.0K | 50.0K | Form 4 ↗ |
MCLAUGHLIN KEVIN F director | May 19, 2026 | Award | 50,000 | $1.04 | $52.0K | 50.0K | Form 4 ↗ |
MCGUIRE TERRANCE director | May 19, 2026 | Award | 50,000 | $1.04 | $52.0K | 50.0K | Form 4 ↗ |
Elia Marc See Remarks | May 19, 2026 | Award | 50,000 | $1.04 | $52.0K | 50.0K | Form 4 ↗ |
BOLNO PAUL director | May 19, 2026 | Award | 32,876 | $1.04 | $34.2K | 32.9K | Form 4 ↗ |
Berry Tamsin director | May 19, 2026 | Award | 50,000 | $1.04 | $52.0K | 50.0K | Form 4 ↗ |
Allen Robert D. III Chief Scientific Officer | Feb 17, 2026 | Sale | 18,189 | $1.54 | $28.0K | 133.9K | Form 4 ↗ |
Allen Robert D. III Chief Scientific Officer | Feb 18, 2026 | Sale | 19,392 | $1.58 | $30.6K | 114.5K | Form 4 ↗ |
Green Julie Chief Human Resources Officer | Feb 17, 2026 | Sale | 19,663 | $1.54 | $30.3K | 128.7K | Form 4 ↗ |
Green Julie Chief Human Resources Officer | Feb 18, 2026 | Sale | 20,964 | $1.58 | $33.1K | 107.7K | Form 4 ↗ |
数据来源：SEC Form 4。买卖方向：acquisitionOrDisposition A=买入，D=卖出。已排除 RSU 归属（M-Exempt）。
关于机构与内部人持股结构
Invivyd, Inc.（IVVD）主要由机构投资者持有，机构持股比例约为 100.0%。公司内部人员持股约 33.83%，散户及公众持股约占剩余的 0.00%。
Invivyd, Inc. 最大机构股东为 JANUS HENDERSON GROUP PLC，截至 September 30, 2025 持有约 25.38 million 股，占总流通股的 14.92%。
目前共有 82 家机构持有 IVVD 股票，合计持仓市值约 $163,792,663，数据来源为最新 SEC 13F 申报。
常见问题
IVVD ownershipInvivyd, Inc.（IVVD）主要由机构投资者持有，机构持股约 100.0%。最大股东为 JANUS HENDERSON GROUP PLC，持股比例 14.92%。内部人员持股约 33.83%。数据来源 SEC Form 13F，截至 September 30, 2025。